ELAN Oct 2024 16.000 call
- Zacks
Elanco Animal Health (ELAN) Upgraded to Buy: Here's Why
Elanco Animal Health (ELAN) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
- PR Newswire
Elanco to Participate in Goldman Sachs 45th Annual Global Healthcare Conference
Elanco Animal Health Incorporated (NYSE: ELAN) will attend the Goldman Sachs 45th Annual Global Healthcare Conference, June 11-12, 2024. Jeff Simmons, President and CEO, will participate in a fireside chat on Tuesday, June 11 at 2:40 p.m. ET.
- PR Newswire
Elanco Announces FDA Has Completed Review of Bovaer®, First-in-Class Methane-Reducing Feed Ingredient, for U.S. Dairy Industry
Elanco Animal Health Incorporated (NYSE: ELAN) today announced the U.S. Food and Drug Administration (FDA) has completed its comprehensive, multi-year review of Bovaer® (3-NOP), a first-in-class methane-reducing feed ingredient, and determined the product meets safety and efficacy requirements for use in lactating dairy cattle.
